Guy Lingani

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Knowledge of the sequence of the human genome has provided significant opportunities to exploit DNA as a target in the rational design of therapeutic agents. Among agents that target DNA, netropsin exhibits a strong preference for binding A/T rich regions. In order to investigate the key factors responsible for DNA recognition and binding by netropsin,(More)
  • 1